Cadrenal Therapeutics, Inc. Common Stock (CVKD)

USD 12.96

(13.19%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022
Total Assets 8.51 Million 778.17 Thousand
Total Current Assets 8.49 Million 727.59 Thousand
Cash And Short Term Investments 8.4 Million 32.58 Thousand
Cash and Cash Equivalents 8.4 Million 32.58 Thousand
Short Term Investments - -
Net Receivables - -
Inventory - -
Other Current Assets 89.67 Thousand 695.01 Thousand
Total Non-Current Assets 27.07 Thousand 50.57 Thousand
Net PPE 23.28 Thousand 44.59 Thousand
Good Will And Intangible Assets - -
Good Will - -
Intangible Assets - -
Long-Term Investments - -
Tax Assets - 532 Thousand
Other Non Current Assets 3792.00 -526.01 Thousand
Other Assets - -
Total Liabilities 826.87 Thousand 6.32 Million
Total Current Liabilities 826.87 Thousand 1.33 Million
Account Payables 167.31 Thousand 404.89 Thousand
Tax Payables - -
Short Term Debt 21.35 Thousand 66.01 Thousand
Deferred Revenue - -
Other Current Liabilities 638.2 Thousand 863.56 Thousand
Total Non Current Liabilities - 4.99 Million
Long-Term Debt - 574.69 Thousand
Deferred Revenue Non Current - -
Deferred Tax Liabilities Non Current - -
Other Non Current Liabilities - 4.42 Million
Other Liabilities - -
Total Equity 7.69 Million -5.55 Million
Stock Holders Equity 7.69 Million -5.55 Million
Common Stock 13.02 Thousand 8194.00
Retained Earnings -15.07 Million -6.71 Million
Accumulated other comprehensive income - -
Common Stock Equity 7.69 Million -5.55 Million
Capital Lease Obligation 21.35 Thousand 43.63 Thousand
Total Investments - -
Total Debt 21.35 Thousand 640.7 Thousand
Net Debt -8.38 Million 608.12 Thousand

Balance Sheet Charts